Friday, November 17, 2017

OIG Outlines Top 10 HHS Challenges Steven Porter, November 16, 2017

Endo scores a victory in its first testosterone bellwether case

'The ongoing class action lawsuit against several makers of testosterone medications hasn’t been going well for AbbVie—it has lost two cases so far—but the legal saga is playing out quite differently for Endo. On Thursday, a federal jury ruled that Endo’s unit Auxilium, which markets the testosterone replacement gel Testim, bears no liability in a case brought by a Tennessee man who alleges he suffered a heart attack after taking the drug."  Read more at:  

Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls

For Immediate Release

November 17, 2017


Update on the efforts by the FDA to address IV fluid shortages exacerbated by Hurricane Maria and advice for hospitals in managing the shortage


It’s been nine weeks since Hurricane Maria made landfall on Puerto Rico and the island continues to struggle to recover from the devastation brought by this storm, as well as Hurricane Irma.
As I’ve commented on previously, the medical products industry has a significant presence in Puerto Rico, and the disruption to this industry has had ramifications for patients both on the island and throughout the U.S. The FDA has been working closely with federal and Puerto Rican authorities to help stabilize the medical products manufacturing sector. We’re taking steps to mitigate or avert product shortages but we’ve still seen shortages of certain medically important products, some of which are sourced primarily or only in Puerto Rico.
Most significantly to date, hospitals across the country are reporting shortages of IV fluids, particularly sodium chloride 0.9% injection bags – a type of saline bag. Saline IV fluids, which are used to inject drugs intravenously in hospital and outpatient settings, have been intermittently in shortage dating back to 2014. However, despite our best efforts, the situation in Puerto Rico has greatly exacerbated this supply issue. The FDA understands the concerns and impact of the ongoing shortages of IV solutions. These products have been on the list of approximately 90 medical products (which includes biologics, devices and drugs) that the FDA has been monitoring since the storm hit, and the FDA is actively working to address the shortage. Among the steps the FDA is taking, in conjunction with manufacturers of these products:
  • temporarily allowing the importation of IV saline products from facilities outside of the U.S.;
  • encouraging the expansion of production at existing facilities to meet shortfalls; and
  • expediting our review of new product applications that will help address this shortage.
For instance, we’re working with one supplier, Baxter, to help them restore operations in their Puerto Rico facilities and move critical ingredients and products onto and off the island. Additionally, the FDA recently approved IV solution products from Fresenius Kabi and Laboratorios Grifols. Both companies are expected to increase production of saline products in the coming weeks. We believe steps like these will help to improve the shortage situation over time.
Beyond these regulatory measures, given the extraordinary situation in Puerto Rico, we have also been working closely with local and federal authorities, and manufacturers of saline and other products, to help address the needs caused by challenges to the basic infrastructure on Puerto Rico. This includes steps to help a subset of critical production facilities gain access to fuel or generators. We’re also connecting companies to other parts of the federal and local government to help clear roads or secure transport priority to import critical raw ingredients.
Going forward, access to reliable power is integral to ensuring Puerto Rico-based medical product manufacturers return to full production capacity quickly. This is the focus of a lot of effort. Unfortunately, most manufacturers are still relying on generator power, and even those that have returned to the electrical grid continue to face interruptions as the grid is rebuilt.
As part of our efforts to reduce the risk of further shortages, the FDA has been working with federal and local government partners to prioritize a small number of critical facilities based on public health needs, including those plants that manufacture IV saline bags, for consideration or prioritization to gain earlier access to the electrical grid. Federal and local authorities have been very responsive to these requests. We’re hopeful that these companies manufacturing medically important products will see their power needs addressed on an accelerated basis. The FDA continues to encourage the companies with FDA-approved saline products to add capacity to meet U.S. demand. We’re also working to identify additional potential manufacturers.
That said, this shortage will require a sustained effort by industry, the agency and other partners to return to production levels that adequately meet the needs of patients. For our part, the FDA will continue to do all we can to address this shortage. We also want to discourage hoarding of products by some healthcare providers. We’re concerned that shortages of some products may be exacerbated in part because of hoarding behavior.
In the meantime, the FDA encourages hospitals to consider clinical recommendations for managing the shortage of these IV fluids, including recommendations by the American Society of Health-System Pharmacists (ASHP) and the University of Utah. The recently released guidance Small-Volume Parenteral Solutions Shortagesdisclaimer icon provides an outline for potential actions for organizations and healthcare professionals to consider in managing the shortage.
The FDA remains committed to fully supporting Puerto Rico’s medical products industry, both as a key aspect of the island’s recovery and in ensuring that Americans continue to have access to the products they need.
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
Page Last Updated: 11/17/2017 

Judge issues 22-page order--Compounder cannot dodge claims by Allergan

Allergan USA, Inc. v. Imprimis Pharmaceuticals, Inc. - Law360

2 days ago - Parties, docket activity and news coverage of federal case Allergan USA, Inc. v. ImprimisPharmaceuticals, Inc., case number 8:17-cv-01551, from California ...

Allergan Lawsuit Against Restasis Competitor Stays Alive | Bloomberg ...

1 day ago - Imprimis Pharmaceuticals Inc. , C.D. Cal., No. 8:17-cv-01551-DOC-JDE, order 11/14/17 ).Allergan's suit against Imprimis highlights the ongoing controversy over ...
Economic burden of opioid epidemic hit $95 billion in 2016
The opioid crisis cost the economy $95 billion in 2016, with $21.4 billion spent on treating patients who suffer from opioid abuse, a new analysis from Altarum found.  READ MORE
Improper Medicare payments drop by nearly $5 billion
The CMS on Wednesday reported that the rate of improper payments doled out by Medicare is the lowest it's been since 2013, accounting for less than 10% of overall Medicare payments.  READ MORE

Breaking News! Hot Topic!! Allergan may pursue lawsuit against drug compounder Imprimis

Allergan may pursue lawsuit against drug compounder Imprimis

Reuters-15 hours ago
Allergan PLC can proceed with a false advertising lawsuit seeking to stop Imprimis Pharmaceuticals Inc from selling compounded drugs that bypass regulatory ...

Only on 27 News: Mercyhealth reacts to Fentanyl shortage at ...

WKOW-13 hours ago
Hurricane Maria is now creating complications for the pharmacy. ... formulas are not available to us, so we have at pharmacy doing more compounding.".

Pfizer warns Nebraska to return any lethal injection drugs it has ...

Omaha World-Herald-19 hours ago
Dunham said the information released so far seems to indicate two possible sources: either a private compounding pharmacy or a distributor that handles Pfizer ...

Neb. quiet on identity of drugs supplier

North Platte Telegraph-4 hours ago
Dunham said the information released so far seems to indicate two possible sources: either a private, compounding pharmacy or a distributor that handles Pfizer ...

Dropless cataract surgery offers cheaper price but possible ...

Healio-21 hours ago
NEW ORLEANS — Dropless cataract surgery is cheaper for the patient and the health care system, but compounding issues and adverse events may be ...

Thursday, November 16, 2017

11/16/2017Greenstone LLC  diphenoxylate hydrochloride and atropine sulfate tablets, USP  Sub Potent and Super Potent TabletsGreenstone LLC, a wholly owned subsidiary of Pfizer Inc.

FDA warns of 'deadly risks' of the herb kratom, citing 36 deaths

Foster's Daily Democrat-9 hours ago
Consumers are increasingly using the supplement, which comes from a plant ... drug and also has taken action against kratom-containing dietary supplements.

FTC Cracks Down on Fake Dietary, Skincare News

Multichannel News-11 hours ago
The court order approved by the Southern District of California "permanently bans the defendants from using negative option features to sell dietary supplements ...

FTC Appeals Ruling over Brain Supplement Prevagen

Natural Products INSIDER (blog)-10 hours ago
The results of the appeal could provide further guidance for marketers of dietarysupplements and others whose advertising practices are routinely policed by the ...

Medicare Seeks Comment On Ways To Cut Costs Of Part D Drugs

Kaiser Health News-37 minutes ago
Insurers and pharmacy benefit managers, or PBMs, administer Medicare's Part D drug program and negotiate behind-the-scenes fees and discounts that are ...

Trump administration proposes Medicare rules aimed at opioids ...

Reuters-45 minutes ago
The agency also plans to revise pharmacy participation rules to promote greater participation of local pharmacies, while preserving beneficiary access to all ...

State pharmacy board says Hillsboro doc indicted on 29 counts

Hillsboro Times Gazette-6 hours ago
On Wednesday, State of Ohio Board of Pharmacy Executive Director Steven W. Schierholt announced that Dr. Timothy S. Manuel, M.D., was indicted on a total of ...

Why Diplomat Pharmacy Inc Fell Today

Motley Fool-6 hours ago
Diplomat Pharmacy (NYSE:DPLO) is down 22% at 1:26 p.m. EST Thursday after announcing after the closing bell yesterday that it's acquiring another pharmacy ...

What Will Happen to FAGRON SA ORD (OTCMKTS:ARSUF) Next ...

KL Daily-12 hours ago
... to Reshape US Sterile Compounding Industry” published on May 04, 2015, ... released by: and their article: “Bellevue Pharmacy notifies state of ...

Area hospitals making adjustments in face of national shortage of IV ...

Omaha World-Herald-13 hours ago
Meantime, the American Society of Health-System Pharmacists has issued guidance with strategies for conserving supplies of the solutions. The group, which ...

Verify: Are all online pet pharmacies illegal and selling bad medicine?

Verify: Are all online pet pharmacies illegal and selling bad medicine?

W*USA 9-21 hours ago
The Pharmacy group has reviewed 11,500 sites and found that 96 percent did not comply with state or federal laws. One to two thousand of them were illegal ...

Lakewood Pharmacy To Repay Medicaid $878K On Prescription

Lakewood Pharmacy To Repay Medicaid $878K On Prescription ... hour ago
Madison Avenue Pharmacy of Lakewood and its owner, David Segal, will repay $878,083 under the settlement announced by state Comptroller Philip James .

Pharmacist facing charges after hundreds of oxycodone pills missing

Pharmacist facing charges after hundreds of oxycodone pills missing

Bradenton Herald-16 hours ago
A Bradenton pharmacist is facing charges after a Manatee County Sheriff's Office investigation revealed that as many as 500 oxycodone pills were missing from ...

Drug Companies Are Warming Up to the Idea of an Amazon Pharmacy

Drug Companies Are Warming Up to the Idea of an Amazon Pharmacy

Bloomberg-3 hours ago
The market is buzzing with speculation that Inc. will enter the pharmacy business. Some drugmakers are just fine with changes the tech retail giant ...

FDA Law Blog - What to Do When You Receive a DEA Order to Show Cause

Fraud in Texas makes clear the need for Congress to not only crack down on Medicare Fraud but also Fraud involving compounding pharmacies

Medicare fraud in Texas makes clear the need for Congress to crack ...

Dallas News-20 hours ago
The recent news surrounding federal prosecutors bringing Medicare fraud cases against doctors, pharmacies and marketers in Texas cities provides some ...

Drug-diversion arrests up 40 percent, attorney general says

Sharonherald-2 hours ago
Metro CreativePennsylvania Attorney General Josh Shapiro is cracking down on doctors, pharmacists and others in health care who would illegally divert ...

Pharmacy profession welcomes prescribing error decriminalisation ...

The Pharmaceutical Journal-20 hours ago
Ken Jarrold, chair of the Rebalancing Medicines Legislation and PharmacyRegulation Programme Board, which drew up recommendations to government ...
World news wrapup: 16 November 2017
Australian Journal of Pharmacy (blog)-22 hours ago

Pharmacies are set for a big dose of Amazon

Financial Times-20 hours ago
One can only admire Amazon's ambition. It expands into ever more distant parts of the retail landscape: industrial supply, streaming video, groceries, fashion.
Rethinking the Role of Pharmacy Benefits
strategy+business (blog)-19 hours ago

Two $2M listings land offers within days

RichmondBizSense-8 hours ago
A fro-yo chain founder and a local pharmacy owner have received offers on their ... Baylor Rice owns South River Compounding Pharmacy, which he and his ...

Compounding Pharmacy's License Suspended

ModernMedicine-17 hours ago
The Vermont Board of Pharmacy suspended a compounding pharmacy's license after finding that the “beyond-use” dates on the drugs exceeded regulations.

Alabama compounding pharmacy's sales rep admits to fraud Reuters · 12 hours ago

Alabama compounding pharmacy's sales rep admits to fraud

Reuters · 12 hours ago

Wednesday, November 15, 2017

Pharmacy profession welcomes prescribing error decriminalisation ...

The Pharmaceutical Journal-1 hour ago
Ken Jarrold, chair of the Rebalancing Medicines Legislation and PharmacyRegulation Programme Board, which drew up recommendations to government ...
World news wrapup: 16 November 2017
Australian Journal of Pharmacy (blog)-3 hours ago

Pharmacist caught with hand in the till

Australian Journal of Pharmacy (blog)-12 hours ago
In December 2011, a pharmacy co-owner overheard a customer complain that the pharmacist had not given her change, and decided to look through the .